Stay informed with the latest litigation news. Explore now

Futher Novel Forms Of Interfering Rna Molecules - EP2258847B2

EP2258847

SILENCE THERAPEUTICS
Application Number
EP10012263A
Filing Date
Aug 5, 2003
Status
Patent Maintained As Amended
May 29, 2020
Grant Date
Jul 1, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2258847B2 was granted to Silence Therapeutics on Jul 1, 2020 following the initial filing on Aug 5, 2003 under the application number EP10012263A . The current legal status of the patent is Patent Maintained As Amended.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANOFIDec 15, 2017WITHDRAWN
THE MEDICINES UKDec 14, 2017WITHDRAWN
ALNYLAM PHARMACEUTICALSOct 19, 2017WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents